Hyperinsulinemia in patients with spastic angina pectoris

Area of Science:

• Cardiology
• Endocrinology
• Metabolic Syndrome Research

Background:

• Angina pectoris is a common cardiovascular condition with various underlying causes.
• Hyperinsulinemia, characterized by high immunoreactive insulin (IRI) levels, is increasingly recognized as a potential contributor to cardiovascular disease.
• The relationship between coronary artery spasm and hyperinsulinemia requires further elucidation.

Purpose of the Study:

• To investigate the association between coronary artery spasm and hyperinsulinemia in patients experiencing angina pectoris.
• To compare IRI levels and glucose metabolism in patients with spastic angina, fixed-obstructive coronary sclerosis, and healthy controls.

Main Methods:

• A cohort study involving 30 patients with spastic angina, 30 with fixed-obstructive coronary sclerosis, and 30 matched controls.
• Performance of a 75-gram oral glucose tolerance test (OGTT) with serial measurements of blood glucose and IRI.
• Measurement of serum total cholesterol, triglyceride, and HDL cholesterol levels.

Main Results:

• Significantly higher IRI levels at 60 minutes, peak IRI, sigma IRI, and the IRI/blood sugar ratio were observed in angina patients compared to controls.
• Patients with fixed-obstructive coronary sclerosis exhibited significantly increased total cholesterol and LDL cholesterol levels compared to controls.
• These findings suggest a strong link between elevated IRI and coronary artery spasm.

Conclusions:

• Hyperinsulinemia is significantly associated with coronary artery spasm in patients with angina pectoris.
• Elevated IRI may play a crucial role in the pathophysiology of spastic angina.
• Further research into the metabolic underpinnings of coronary artery disease is warranted.